140 filings
Page 2 of 7
D
t2rgokn xd4l0zv0r7
3 Nov 23
$2.00 mm in equity, sold $2.00 mm, 1 investor
2:03pm
8-K
5e8613il mrdcru
27 Oct 23
Coeptis Therapeutics Announces $2 Million Private Placement
4:01pm
8-K
r45ja 9q2lxb
12 Oct 23
Unregistered Sales of Equity Securities
6:46pm
424B3
n4p q768cr0
26 Sep 23
Prospectus supplement
4:01pm
8-K
0mqruqu on7ybp4
30 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
654t0er3nzoo7 bukz
22 Aug 23
Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra Therapeutics
4:01pm
8-K
stsxwxc
16 Jun 23
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million
5:15pm
424B4
s7nt5andu m7opzg
15 Jun 23
Prospectus supplement with pricing info
9:25am
S-1MEF
8bohr0xx4 whx4
14 Jun 23
Registration of additional securities for an S-1
8:30am
EFFECT
f8s1vma
14 Jun 23
Notice of effectiveness
12:15am
S-1MEF
w66c8gh8o96owwwcuwy
13 Jun 23
Registration of additional securities for an S-1
9:55pm
CORRESP
gl8i3yrwzsgo s76
12 Jun 23
Correspondence with SEC
12:00am
CORRESP
ntgndl vno
12 Jun 23
Correspondence with SEC
12:00am
8-K
g7a1t3v
9 Jun 23
Coeptis Therapeutics Receives Approval to Transfer to The Nasdaq Capital Market
4:15pm